Status epilepticus (SE) is the most common neurological emergency encountered in childhood; therefore, care providers need to be aware of the acute and chronic implications to accurately counsel patients and their families. 1 The umbrella diagnosis of SE includes numerous subtypes: electrographic SE, convulsive SE, focal SE with impaired consciousness, and absence SE. The most recent guidelines from the International League Against Epilepsy (ILAE) provide two convulsive SE timepoints: the time at which continuous seizure activity requiring the administration of an emergency medication is likely (5 min), and the time at which a continued seizure might lead to permanent neuronal damage (30 min). 2 Unfavorable short-term outcomes after SE, such as in-hospital mortality and maintenance of normal endothelial function. Hence, the model links placental dysfunction to maternal endothelial dysfunction, the cardinal feature of pre-eclamspia. Genome-wide association studies and exome sequencing data for pre-eclampsia have identified variants associated with the FLT1 gene and such observations strongly support a causal role for sFLT1 in the cause of pre-eclampsia. 7, 8 This role of elevated sFLT1 raises the possibility of targeted therapies to manipulate the system. One approach is to use therapeutic apheresis to remove sFLT1 from the serum of women with severe, early-onset pre-eclampsia. 9 Another targeted approach to novel therapies, which manipulate angiogenic pathways, is the use of gene therapy, which is being developed for severe, early-onset fetal growth restriction. Adenoviral vectors with the VEGF gene are delivered to the uterine artery, inducing both short-term changes in smooth muscle contraction and promoting long-term changes through vascular remodelling. 10 The hope is that correcting maternal underperfusion of the placenta will enhance placental transfer, correcting a key factor in the pathogenesis of the disease.
Although early-onset fetal growth restriction and pre-eclampsia are both rare, the huge lifelong costs of these outcomes justify a substantial focus of resources on research. Doing nothing will result in persistently high rates of stillbirth and cohorts of impaired children, with resulting societal and economic costs. But progress depends on strong candidate therapies and these therapies in turn depend on knowledge of the mechanisms of diseases related to the placenta. Very basic questions remain unanswered. Why do the risks of these conditions vary according to the sex of the fetus? Why is it that placental dysfunction can lead to preeclampsia without fetal growth restriction, fetal growth restriction without pre-eclampsia, or the coexistence of both conditions? Hence, basic and translational research are the vital prerequisites to trials such as STRIDER. As the present study shows, however effective the network and trial design, interventional studies will only be as useful as the candidate drugs they evaluate. neurological morbidity at hospital discharge, have been shown across several paed iatric cohorts, in both convulsive and non-convulsive SE. 3, 4 Suresh Pujar and colleagues 5 describe long-term neuro logical outcomes (including development of epilepsy, motor and intellectual disability, and educational difficulties) for a cohort of children with convulsive SE followed for a median of 8·9 years. In this population-based study that prospectively monitored the natural course of paediatric patients with convulsive SE, 66% of survivors from their original cohort 6 participated, and there were no significant difference in baseline demo graphic characteristics between participants with and without follow up. The primary take-away point from the study is that longterm neurological outcomes in children after convulsive SE are quite varied and highly correlated with baseline neurological status. The data from this study suggest that previously neurologically intact children presenting with an acute febrile illness or acute symptomatic cause of convulsive SE who survive have a low risk of developing new, long-term neurological morbidity. The cumulative incidence of epilepsy in the cohort was 24·7%, with all epilepsies presenting within the first 5 years following the episode of SE. The lowest incidence of epilepsy was in prolonged febrile SE (14·3%) and the highest incidences of epilepsy were in remote symptomatic SE (45·5%) and unclassified SE (50·0%). There was also a small risk for incident development of motor and intellectual disability in the total cohort, with a cumulative incidence of 2·1% for motor disability and 8·8% for intellectual disability. The presence of preexisting epilepsy served as the only significant predictor of intellectual disability. Educational support has had varied use in the cohort; 5·7% of patients with prolonged febrile SE and no patients with acute symptomatic SE used educational supports compared with 89·5% of patients with idiopathic convulsive SE and 86·8% of patients with remote symptomatic convulsive SE. By contrast, children who develop SE in the context of an established neurological disorder are at significantly increased risk for neurological morbidity, including worsening neurological status.
Although this study was able to stratify patients by baseline neurological status, future studies could assess the burden of pre-convulsive SE neurological disease so that the degree of worsening conferred by an episode of convulsive SE is better defined. Future studies could focus on the effects of seizure burden (which might carry various definitions-total number of minutes with seizure, maximal hour percentage with seizure, or refractoriness to treatment) in long-term outcomes of children with SE. A single study 7 of the relationship between electrographic seizure burden and short-term outcomes in neonates and children with electrographic SE showed no association between seizure burden (defined as maximum percentage of any hour occupied by electrographic seizure) and mortality, but escalating seizure burden was associated with increased probability of neurological decline (defined as a worsening Pediatric Cerebral Performance Category score at hospital discharge). This work has not yet been replicated in convulsive SE. Given that timely antiseizure medication administration results in improved efficacy of the medication in children who are critically ill, 8 future studies could determine whether earlier initiation of treatment for convulsive SE would result in decreased seizure burden, and whether such a reduction was associated with improved long-term neurological outcomes.
The current study focused on clinically detected con vulsive SE, but concordant EEG data was not consistently recorded or reported. Future studies of convulsive SE could also include EEG analysis after the initial convulsive period, because additional information such as the presence of subclinical seizures or the persistence of an abnormal EEG background might offer additional prognostic information. Important differences in long-term outcomes might be explained not only by SE causes, but also by SE type. Previous work has suggested unfavourable long-term neurobehavioral outcomes among previously neurologically intact children after electrographic SE, 9 a finding that diverges from the results of the current study of convulsive SE.
With growing evidence of the link between abnormal cerebral metabolites and unfavourable outcomes in critically ill adult populations with acute brain injury, 10 a potential future goal of neuromonitoring in children with SE could also include microdialysis of CSF obtained both during and after SE. The evolution of neurometabolites (eg, glucose, lactate, pyruvate, neurofilament light chain) during and after an episode of SE might provide additional functional data, which is currently unavailable with standard EEG analysis, that could inform differences in outcomes experienced by different paediatric SE strata.
The largest epidemiological report on paediatric acute kidney injury is the Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology (AWARE) study, 1 which applied criteria from the Kidney Disease: Improving Global Outcomes (KDIGO) study 2 (table) to a multinational cohort of about 4500 patients. This study showed that acute kidney injury occurred in 26% of patients within 7 days of admission to a paediatric intensive care unit (ICU) and that it caused a consistently increased risk of death in patients with severe acute kidney injury (KDIGO stages 2 and 3), even after adjustment for multiple covariates. 2 Unlike acute coronary syndromes, acute kidney injury is painless. Furthermore, whereas the nature of angina pectoris is ischaemic, acute kidney injury follows complex pathophysiological pathways, is rarely ischaemic, mostly multifactorial, 3 and generally part of multiple organ dysfunction. 4 For these reasons, although troponin might be measured for early diagnosis of acute coronary syn dromes, the diagnostic capacity of renal biomarkers is challenged by the absence of warning pain from the silent kidneys. 5, 6 With these aspects in mind, Rajit Basu and colleagues conceived the concept of a renal angina index. 7 The index does not use any pain symptoms, but is calculated from the multiplication of scores for clinical risk and renal injury. The idea is that a patient with a positive index score (≥8) should be managed, from a renal standpoint, with a similar timing to that for an anginous patient, before irreversible damage occurs. Children are generally admitted to general paediatric ICUs following disparate clinical events such as surgical procedures or complications of acute or chronic illnesses (eg, fluid overload, respiratory failure, heart failure, or septic shock). In this context, some easy, inexpensive, and widely available screening tools are required for use by paediatric intensivists. 8 Just as angina warns about myocardial damage within a specific time window, a patient with a positive score on the renal angina index at admission to a paediatric ICU is assessed for occurrence of acute kidney injury or its persistence 3 days after admission. 9 In The Lancet Child & Adolescent Health, Basu and coworkers 10 ambitiously applied this theoretical background to data from the AWARE study. 1 Because of the strict inclusion criteria, only patients with complete data for days 0, 3, and 28, and admission to a paediatric ICU lasting more than 3 days were included. A positive score on the renal angina index within the first 12 h of admission showed a clear association with a two-fold incidence of day 3 severe acute kidney injury (the primary outcome), which occurred in 121 (42%) patients positive for renal angina and 247 (19%) patients negative for renal angina (relative risk [RR] 2·23, 95% CI 1·87-2.66, p<0·0001), prolonged mechanical ventilation, increased need for renal replacement, and higher risk of mortality when compared to children with a negative index score. The investigators repeatedly showed that renal angina index positivity is a better means of anticipating severe day 3 acute kidney injury than increases in serum creatinine during the first 12 h after admission to a paediatric ICU. However, the number of patients with
